Precision ETS
Improving embryo transfer in In Vitro Fertilization (IVF)
Pre-clinicalActive
Key Facts
Indication
Improving embryo transfer in In Vitro Fertilization (IVF)
Phase
Pre-clinical
Status
Active
Company
About Faberge Fertility
Faberge Fertility is an early-stage biotech company founded in 2020, operating at the intersection of reproductive health and digital health. Its core innovation is the Precision ETS, a medical device aimed at enhancing the precision and success of embryo transfers during IVF procedures. The company is supported by the University of Minnesota's startup ecosystem and the Red Wing Ignite incubator, with a leadership team combining clinical and engineering expertise. It is currently pre-revenue and in the development phase, seeking regulatory approval for its novel system.
View full company profile